Invesaro

Stocks Health care PFE

NYSE · Health care

Pfizer Inc (PFE)

Pfizer Inc brought in $63.7B of revenue over the twelve months to June 28, 2026, down 0.2% from a year earlier. Net income was $4.3B, a net margin of 6.8%. Operating cash flow minus capital spending left $9.1B of free cash flow in fiscal 2025. At June 28, 2026 it held $976M in cash against $63.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price
$28.67
+0.92% on the day · September 25, 2026
52-week range $23.62 to $29.21
Market cap
$163.4B
Revenue (last 12 months)
$63.7B
-0.2% year on year
Net margin
6.8%
P/E
21.1
on FY2025 diluted EPS

What Pfizer Inc does

Pfizer discovers, develops, manufactures, and sells prescription medicines and vaccines. Its products treat conditions in oncology, cardiology, immunology, and infectious diseases. Customers include healthcare providers, hospitals, pharmacies, and government agencies worldwide. Its shares trade on NYSE under the ticker PFE.

Revenue and profit by year

Revenue
FY18: $40.8B $40.8B FY18FY19: $40.9B $40.9B FY19FY20: $41.7B $41.7B FY20FY21: $81.3B $81.3B FY21FY22: $101.2B $101.2B FY22FY23: $59.6B $59.6B FY23FY24: $63.6B $63.6B FY24FY25: $62.6B $62.6B FY25
Net income
FY18: $11.2B $11.2B FY18FY19: $16B $16B FY19FY20: $9.2B $9.2B FY20FY21: $22B $22B FY21FY22: $31.4B $31.4B FY22FY23: $2.1B $2.1B FY23FY24: $8B $8B FY24FY25: $7.8B $7.8B FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$62.6Bn/a$7.8B$1.36$9.1B
2024$63.6Bn/a$8B$1.41$9.8B
2023$59.6Bn/a$2.1B$0.37$4.8B
2022$101.2Bn/a$31.4B$5.47$26B
2021$81.3Bn/a$22B$3.85$29.9B
2020$41.7Bn/a$9.2B$1.63$12.2B

Latest SEC filings

What Pfizer Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 31, 2026
  2. August 13, 2026
  3. August 4, 2026
    Quarterly report 10-Q · period to June 28, 2026
  4. August 4, 2026
  5. June 18, 2026
  6. June 18, 2026
  7. June 16, 2026
  8. June 16, 2026
  9. May 12, 2026
  10. May 12, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 16, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about PFE

What does Pfizer Inc do?

Pfizer discovers, develops, manufactures, and sells prescription medicines and vaccines. Its products treat conditions in oncology, cardiology, immunology, and infectious diseases. Customers include healthcare providers, hospitals, pharmacies, and government agencies worldwide. Its shares trade on NYSE under the ticker PFE.

Is Pfizer Inc profitable?

Yes. Over the twelve months to June 28, 2026 it reported net income of $4.3B on revenue of $63.7B, a net margin of 6.8%.

How much revenue does Pfizer Inc make?

Over the twelve months to June 28, 2026 Pfizer Inc reported revenue of $63.7B. That is 0.2% less than a year earlier.

When did Pfizer Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 28, 2026. Its newest filing of any kind is the insider trade from September 16, 2026.

Similar companies

Follow PFE

Get an email when Pfizer Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow PFE: get an email when it files

Where the numbers come from

Financial figures are the values Pfizer Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.